Financial cost of assisted reproductive technology for patients in high-income countries: A systematic review protocol.

ABSTRACT:

Background

Infertility affects one in six people globally, with similar prevalence rates across high-income and low- and middle-income countries. Technological advancements, particularly in Assisted Reproductive Technology (ART), have improved fertility treatment options. Although access to ART is presumed to be better in high-income countries (HICs), economic factors and eligibility restrictions could still impact effective utilization in these settings. Informed by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses protocols (PRISMA-P), this protocol outlines the methodological and analytical approaches to examine the ART costs paid by patients in HICs and the correlation with economic indicators and ART regulatory frameworks.

Methods

Following the PRIS

SUBMITTER: Njagi P 

PROVIDER: S-EPMC11825044 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature